Cited by 94Lipoproteins and Cardiovascular HealthCoronary Interventions and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins

Diabetes Mellitus Is a Major Negative Determinant of Coronary Plaque Regression During Statin Therapy in Patients With Acute Coronary Syndrome - Serial Intravascular Ultrasound Observations From the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial) -

Open access
Hiro, Takafumi, Kimura, Takeshi, Morimoto, Takeshi, Miyauchi, Katsumi, Nakagawa, Yoshihisa, Yamagishi, Masakazu, Ozaki, Yukio, Kimura, Kazuo +5 more·2010·Circulation Journal

Abstract

BACKGROUND: The Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) trial has found that early aggressive statin therapy in patients with acute coronary syndrome (ACS) significantly reduces the plaque volume (PV) of non-culprit coronary lesions. The purpose of the present study was to evaluate clinical factors that have an impact on plaque regression using statin therapy. METHODS AND RESULTS: Serial intravascular ultrasound observations over 8-12 months were performed in 252 ACS patients receiving pitavastatin or atorvastatin. Linear regression analysis identified the presence of diabetes mellitus (DM) and PV at baseline as inhibiting factors, and serum remnant-like particle-cholesterol level at baseline as a significant factor significantly affecting the degree of plaque regression. Significant correlation between % change of PV and low-density lipoprotein cholesterol (LDL-C) level was found in patients with DM (n=73, P<0.05, r=0.4), whereas there was no significant correlation between the 2 parameters in patients without DM (n=178). CONCLUSIONS: The regression of coronary plaque induced by statin therapy after ACS was weaker in diabetic patients than their counterparts. Moreover, vigorous reduction of the LDL-C levels might induce a greater degree of plaque regression in ACS patients with DM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1253/circj.cj-09-0766

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the sub-analysis of the TNT study, treatment using a high statin dose significantly suppressed cardiovascular and cerebrovascular events by 25% and 31%, respectively, compared with treatment using the usual statin dose in subjects with coronary artery disease complicated with diabetes.

    “In the sub-analysis of the TNT study, which involved subjects with CAD complicated with diabetes, treatment using a high statin dose significantly suppressed cardiovascular and cerebrovascular events by 25% and 31%, respectively, compared to treatment using the usual statin dose753).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hiro, T., Kimura, T., Morimoto, T., Miyauchi, K., Nakagawa, Y., Yamagishi, M., Ozaki, Y., Kimura, K., Saito, S., Yamaguchi, T., Daida, H., Matsuzaki, M., & The JAPAN-ACS Investigators
Affiliations
  • Nihon University (JP)
  • Department of Cardiovascular Medicine
  • Kyoto University (JP)
  • Juntendo University (JP)
  • Tenri Hospital (JP)
  • Kanazawa University (JP)
  • Fujita Health University (JP)
  • Yokohama City University Medical Center (JP)
  • Division of Cardiovascular Medicine, Keiai Hospital
  • Toranomon Hospital (JP)
  • Yamaguchi University (JP)
Venue
Circulation Journal
Published
2010
Volume
74
Issue
6
Pages
1165-1174
ISSN
  • 1346-9843 (ISSN-L)
  • 1347-4820
OpenAlex
W2076069465
Cited by
94
References
26
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 5 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 11 · 2012: 13
FWCI
11.53
Type
journal article
Language
en
Open access
Locations
  • Circulation Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
Funders
  • Kowa Company
  • Wakayama Medical University
  • Fukuoka University
  • Fujita Health University
  • Japan Heart Foundation
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetes mellitus, coronary plaque regression, acute coronary syndrome, statin therapy, pitavastatin, atorvastatin, plaque volume, remnant-like particle cholesterol, LDL cholesterol
MeSH terms
Atorvastatin, Aged, Coronary Artery Disease, Diabetes Mellitus, Female, Heptanoic Acids, Humans, Male, Middle Aged, Pyrroles, Quinolines, Treatment Outcome, Ultrasonography, Interventional, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Acute Coronary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review